Skip to ContentSkip to Navigation
Practical matters How to find us ing. D.F. Samplonius

Publications

A proof-of-concept study on the use of a fluorescein-based 18F-tracer for pretargeted PET

Bispecific antibody CD73xEpCAM selectively inhibits the adenosine-mediated immunosuppressive activity of carcinoma-derived extracellular vesicles

Cancer cells under immune attack acquire CD47-mediated adaptive immune resistance independent of the myeloid CD47-SIRP alpha axis

Corrigendum: Modular Medical Imaging Agents Based on Azide-Alkyne Huisgen Cycloadditions: Synthesis and Pre-Clinical Evaluation of F-18-Labeled PSMA-Tracers for Prostate Cancer Imaging (vol 26, pg 10871, 2020)

Synthesis and Evaluation of F-18-Enzalutamide, a New Radioligand for PET Imaging of Androgen Receptors: A Comparison with 16 beta-F-18-Fluoro-5 alpha-Dihydrotestosterone

Bispecific antibody approach for EGFR-directed blockade of the CD47-SIRP alpha "don't eat me" immune checkpoint promotes neutrophil-mediated trogoptosis and enhances antigen cross-presentation

Modular Medical Imaging Agents Based on Azide-Alkyne Huisgen Cycloadditions: Synthesis and Pre-Clinical Evaluation of(18)F-Labeled PSMA-Tracers for Prostate Cancer Imaging

A light-responsive liposomal agent for MRI contrast enhancement and monitoring of cargo delivery

Bispecific Antibody Approach for Improved Melanoma-Selective PD-L1 Immune Checkpoint Blockade

Quantitative proteomics analysis identifies MUC1 as an effect sensor of EGFR inhibition

Read more